Cargando…

DNA Immunization with Fusion of CTLA-4 to Hepatitis B Virus (HBV) Core Protein Enhanced Th2 Type Responses and Cleared HBV with an Accelerated Kinetic

BACKGROUND: Typically, DNA immunization via the intramuscular route induces specific, Th1-dominant immune responses. However, plasmids expressing viral proteins fused to cytotoxic T lymphocyte antigen 4 (CTLA-4) primed Th2-biased responses and were able to induced effective protection against viral...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Ying, Wu, Chunchen, Song, Jingjiao, Wang, Junzhong, Zhang, Ejuan, Liu, Hongyan, Yang, Dongliang, Chen, Xinwen, Lu, Mengji, Xu, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142188/ https://www.ncbi.nlm.nih.gov/pubmed/21799884 http://dx.doi.org/10.1371/journal.pone.0022524

Ejemplares similares

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication In Vivo
por: Zhu, Wenbo, et al.
Publicado: (2012)

Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B
por: Li, Lei, et al.
Publicado: (2013)

The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model
por: Li, Lei, et al.
Publicado: (2017)

Immunosuppressive Drugs Modulate the Replication of Hepatitis B Virus (HBV) in a Hydrodynamic Injection Mouse Model
por: Wang, Junzhong, et al.
Publicado: (2014)

Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection
por: Zhang, Ejuan, et al.
Publicado: (2014)

Persistence of the Recombinant Genomes of Woodchuck Hepatitis Virus in the Mouse Model
por: Pan, Danzhen, et al.
Publicado: (2015)

Different antiviral effects of IFNα subtypes in a mouse model of HBV infection
por: Song, Jingjiao, et al.
Publicado: (2017)

Enhanced host immune responses in presence of HCV facilitate HBV clearance in coinfection
por: Liu, Shuhui, et al.
Publicado: (2022)

HBV Core Promoter Inhibition by Tubulin Polymerization Inhibitor (SRI-32007)
por: Kalkeri, Raj, et al.
Publicado: (2020)

HBV sL13H mutation impairs its surface antigen expression and ability to induce autophagy
por: Xia, Jianbo, et al.
Publicado: (2022)

CTLA-4 interferes with the HBV-specific T cell immune response (Review)
por: Cao, Hui, et al.
Publicado: (2018)

Upregulation of HBV transcription by sodium taurocholate cotransporting polypeptide at the postentry step is inhibited by the entry inhibitor Myrcludex B
por: Zhao, Kaitao, et al.
Publicado: (2018)

Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection
por: Du, Yanqin, et al.
Publicado: (2022)

New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
por: Lim, Young-Suk
Publicado: (2023)

Vitamin D signaling inhibits HBV activity by directly targeting the HBV core promoter
por: Ahluwalia, Shivaksh, et al.
Publicado: (2021)

HBV Core Protein Enhances Cytokine Production
por: Kanda, Tatsuo, et al.
Publicado: (2015)

The HBV Core Protein and Core Particle Both Bind to the PPiase Par14 and Par17 to Enhance Their Stabilities and HBV Replication
por: Saeed, Umar, et al.
Publicado: (2021)

Productive HBV infection of well-differentiated, hNTCP-expressing human hepatoma-derived (Huh7) cells
por: Zhou, Ming, et al.
Publicado: (2017)

Targeting the HIV-1 and HBV Capsids, an EnCore
por: McFadden, William M., et al.
Publicado: (2023)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

High pretransplant HBV level predicts HBV reactivation after kidney transplantation in HBV infected recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
por: Yuan, Si-Yu, et al.
Publicado: (2022)

Intrahepatic quantification of HBV antigens in chronic hepatitis B reveals heterogeneity and treatment-mediated reductions in HBV core-positive cells
por: Aggarwal, Abhishek, et al.
Publicado: (2022)

MicroRNAs Associated With HBV Infection And HBV-related HCC
por: Xie, Kun-Lin, et al.
Publicado: (2014)

HBV cccDNA: The Stumbling Block for Treatment of HBV Infection
por: Liu, Shousheng, et al.
Publicado: (2019)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015)

HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance
por: Xie, Xiaohong, et al.
Publicado: (2021)

Epigenetic regulation of HBV-specific tumor-infiltrating T cells in HBV-related HCC
por: You, Maojun, et al.
Publicado: (2023)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

PreC and C Regions of Woodchuck Hepatitis Virus Facilitate Persistent Expression of Surface Antigen of Chimeric WHV-HBV Virus in the Hydrodynamic Injection BALB/c Mouse Model
por: Wu, Weimin, et al.
Publicado: (2017)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia
por: Belyhun, Yeshambel, et al.
Publicado: (2018)

Hepatitis B virus (HBV)-specific T-cell responses to recombinant HBV core protein in patients with normal liver function and co-infected with chronic HBV and human immunodeficiency virus 1 (HIV-1)
por: Zhang, Xin, et al.
Publicado: (2013)

Impact of HCV viremia on HBV biomarkers in patients coinfected with HBV and HCV
por: Tseng, Chih-Wei, et al.
Publicado: (2022)

HBV-HCC treatment with mRNA electroporated HBV-TCR T cells
por: Tan, Anthony T, et al.
Publicado: (2021)

CTLA4(+)CD4(+)CXCR5(−)FOXP3(+) T cells associate with unfavorable outcome in patients with chronic HBV infection
por: Wen, Chunhua, et al.
Publicado: (2023)

HBV integrated genomic characterization revealed hepatocyte genomic alterations in HBV-related hepatocellular carcinomas
por: Yang, Ming, et al.
Publicado: (2020)

HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
por: Horng, Jau-Hau, et al.
Publicado: (2020)

HBV Core Protein Is in Flux between Cytoplasmic, Nuclear, and Nucleolar Compartments
por: Nair, Smita, et al.
Publicado: (2021)

Clinical Utility of Quantitative HBV Core Antibodies for Solving Diagnostic Dilemmas
por: Lazarevic, Ivana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_084ud3chntag3fd5l41hj9a88s